Texas program offers funding, services to health IT startups

Laura Pedulli | | Health Exec | Digital Transformation

Health Wildcatters, a mentorship-driven seed accelerator based in Dallas, is offering 15 health IT startups up to $35,000 and 12 weeks of educational training to get their ideas and businesses off the ground. Companies also may receive up to $250,000 in follow-on funding, according to the Health Wildcatters website.

The accelerator is requesting applications from interested companies involved in healthcare IT, SaaS, digital health, mobile health companies, medical devices, diagnostic or drugs. Those who secure a spot are partnered with mentors, advisors, capital, connections and strategic resources. The 12-week program ends with a pitchday for Dalls investors; some startups will attend the mHealth summit in Washington, DC in December and meet with east and west coast venture capitalists, according to the website.

“The specific challenges of selling into the healthcare market, dealing with regulatory constraints and the slower pace of adoption are why we are here,” explained the Health Wildcatters website.

In exchange for the investment and support, Health Wildcatters receives 8 percent of the company’s funding stock, but holds no rights to make any decisions for the company.

Laura Pedulli

Related Content

10 signs AI is ‘eating the world (of venture capital)’
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy
Healthcare AI regulation needs nuance, balance: Research review
ICU diary-keeping: There’s an AI for that
Stanford HAI lookback: Best-read blog posts of 2024
Providers, payers share actionable experiences involving healthcare AI

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.